Occurrence of comorbidities in newly diagnosed type 2 diabetes patients and their impact after 11 years’ follow-up
Abstract The burden of type 2 diabetes is growing, not only through increased incidence, but also through its comorbidities. Concordant comorbidities for type 2 diabetes, such as cardiovascular diseases, are considered expected outcomes of the disease or disease complications, while discordant comor...
Enregistré dans:
Auteurs principaux: | Sophia Eilat-Tsanani, Avital Margalit, Liran Nevet Golan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2f47ec89e0e9477bb2bc99b54413192f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Fractal analysis of 11C-methionine PET in patients with newly diagnosed glioma
par: Yukito Maeda, et autres
Publié: (2021) -
Comparing the predictive accuracy of frailty, comorbidity, and disability for mortality: a 1-year follow-up in patients hospitalized in geriatric wards
par: Ritt M, et autres
Publié: (2017) -
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
par: Judith E Karp, et autres
Publié: (2008) -
Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction
par: Yuki Obayashi, et autres
Publié: (2021) -
Newly Diagnosed Infection After Admission for Acute Heart Failure: From the KCHF Registry
par: Yuta Seko, et autres
Publié: (2021)